Nkarta Inc (NKTX)

[jondoeuk]

ADAM17 knockout NK or CAR NK cells augment antibody dependent cellular cytotoxicity (ADCC) and anti-tumor activity https://www.abstractsonline.com/pp8/#!/10828/presentation/3022

Combination of anti-EGFR antibody cetuximab with NKX101, an allogeneic NKG2D-L targeting NK cell therapy, enhances potency and in vitro cytotoxicity against solid tumors https://www.abstractsonline.com/pp8/#!/10828/presentation/3049